Innoviva elects six directors at annual meeting; say-on-pay passes

Innoviva, Inc.

Shareholders elected 6 directors at Apr 25, 2022 meeting; each term expires at 2023 annual meeting.
Dr. Sarah Schlesinger received 36.6M votes for, 16.7M against/abstain — highest opposition among nominees.
Say-on-pay advisory vote approved: 51.5M for, 1.7M against, 0.1M abstain, 5.1M broker non-votes.
Ratification of Deloitte & Touche as auditor for FY2022: 58.0M for, 0.3M against, 23k abstain.
Broker non-votes of ~5.1M shares on director elections and say-on-pay proposal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.